drugset / Trial / NCT00865371
A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to compare the rate and extent of absorption of Abrika Bupropion 150 mg Extended-Release Tablet to that of Wellbutrin SR® 150 mg Tablet after a single, one-tablet dose in subjects fed a standard meal.
Timeline
- Start
- 2004-09
- Primary completion
- 2004-09
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 150 mg | — |
Indications
No indication recorded.